Posterior laryngitis: A study of persisting symptoms and health-related quality of life

European Archives of Oto-Rhino-Laryngology

Volumn 270, Issue 1, 2013, Pages 187-195

  Pendleton, Hillevi ^a   Ahlner Elmqvist, Marianne ^b   Jannert, Magnus ^a   Ohlsson, Bodil ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Health related quality of life; Posterior laryngitis

Indexed keywords

ALGINIC ACID; ALUMINUM HYDROXIDE; ANTIHISTAMINIC AGENT; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CONSULTATION; COUGHING; ESOPHAGUS MANOMETRY; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HEARTBURN; HOARSENESS; HUMAN; LARYNGITIS; LARYNGOSCOPY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; POSTERIOR LARYNGITIS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RETROSPECTIVE STUDY; SHORT FORM 36; SORE THROAT; SYMPTOM;

FEMALE; HUMANS; LARYNGITIS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 84872321006     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-012-2116-2     Document Type: Article

References (28)

1. Koufman JA, Amin MR, Panetti M (2000) Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders. Otolaryngol Head Neck Surg 123(4):385-388. doi: 10.1067/mhn.2000.109935
2. Hopkins C, Yousaf U, Pedersen M (2006) Acid reflux treatment for hoarseness. Cochrane Database Syst Rev (1):CD005054
3. Barry DW, Vaezi MF (2010) Laryngopharyngeal reflux: more questions than answers. Cleve Clin J Med 77(5):327-334. doi: 10.3949/ccjm.77a.09121
4. Kotby MN, Hassan O, El-Makhzangy AM, Farahat M, Milad P (2010) Gastroesophageal reflux/laryngopharyngeal reflux disease: a critical analysis of the literature. Eur Arch Otorhinolaryngol 267(2):171-179. doi: 10.1007/s00405-009-1176-4
5. Belafsky PC, Postma GN, Koufman JA (2001) Laryngopharyngeal reflux symptoms improve before changes in physical findings. Laryngoscope 111(6):979-981. doi: 10.1097/00005537-200106000-00009 (Pubitemid 32523703)
6. Jones R, Coyne K, Wiklund I (2007) The gastro-oesophageal reflux disease impact scale: a patient management tool for primary care. Aliment Pharmacol Ther 25(12):1451-1459. doi: 10.1111/j.1365-2036.2007.03343.x (Pubitemid 46848895)
7. Winstead W, Barnett SN (1998) Impact of endoscopic sinus surgery on global health perception: an outcomes study. Otolaryngol Head Neck Surg 119(5):486-491 (Pubitemid 28525071)
8. Nordin K, Pahlman L, Larsson K, Sundberg-Hjelm M, Loof L (2002) Health-related quality of life and psychological distress in a population-based sample of Swedish patients with inflammatory bowel disease. Scand J Gastroenterol 37(4):450-457 (Pubitemid 34274330)
9. Sullivan M, Karlsson J, Taft C (2002) SF-36: Swedish manual and interpretation guide, 2nd edn.Sahlgrenska University Hospital, Gothenburg
10. Korkmaz M, Tarhan E, Unal H, Selcuk H, Yilmaz U, Ozluoglu L (2007) Esophageal mucosal sensitivity: possible links with clinical presentations in patients with erosive esophagitis and laryngopharyngeal reflux. Dig Dis Sci 52(2):451-456. doi: 10.1007/s10620-006-9514-5 (Pubitemid 46202820)
11. Tibblin G, Bengtsson C, Furunes B, Lapidus L (1990) Symptoms by age and sex. The population studies of men and women in Gothenburg, Sweden. Scand J Prim Health Care 8(1):9-17 (Pubitemid 20214594)
12. Simren M, Abrahamsson H, Svedlund J, Bjornsson ES (2001) Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern. Scand J Gastroenterol 36(5):545-552 (Pubitemid 32328447)
13. Dimenas E, Carlsson G, Glise H, Israelsson B, Wiklund I (1996) Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol Suppl 221:8-13 (Pubitemid 27023576)
14. Sataloff RT, Hawkshaw MJ, Gupta R (2010) Laryngopharyngeal reflux and voice disorders: an overview on disease mechanisms, treatments, and research advances. Discov Med 10(52):213-224
15. Khan AM, Hashmi SR, Elahi F, Tariq M, Ingrams DR (2006) Laryngopharyngeal reflux: a literature review. Surgeon 4(4):221-225 (Pubitemid 44165022)
16. Vaezi MF, Richter JE, Stasney CR, Spiegel JR, Iannuzzi RA, Crawley JA, Hwang C, Sostek MB, Shaker R (2006) Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope 116(2):254-260. doi: 10.1097/01.mlg.0000192173. 00498.ba (Pubitemid 44383934)
17. Pearson JP, Parikh S, Orlando RC, Johnston N, Allen J, Tinling SP, Belafsky P, Arevalo LF, Sharma N, Castell DO, Fox M, Harding SM, Morice AH, Watson MG, Shields MD, Bateman N, McCallion WA, van Wijk MP, Wenzl TG, Karkos PD, Belafsky PC (2011) Review article: reflux and its consequences - the laryngeal, pulmonary and oesophageal manifestations. In: Conference held in conjunction with the 9th international symposium on human pepsin (ISHP) Kingston-upon-Hull, UK, 21-23 April 2010. Aliment Pharmacol Ther 33(Suppl 1):1-71. doi: 10.1111/j.1365-2036.2011.04581.x
18. Kahrilas PJ, Hughes N, Howden CW (2011) Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease. Gut 60(11):1473-1478. doi: 10.1136/gut.2011.241307
19. Tamhankar AP, Peters JH, Portale G, Hsieh CC, Hagen JA, Bremner CG, DeMeester TR (2004) Omeprazole does not reduce gastroesophageal reflux: new insights using multichannel intraluminal impedance technology. J Gastrointest Surg 8(7):890-897. doi: 10.1016/j.gassur.2004.08.001 discussion 897-898 (Pubitemid 41115744)
20. Tack J (2005) Review article: role of pepsin and bile in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 22(Suppl 1):48-54. doi: 10.1111/j.1365-2036.2005.02609.x (Pubitemid 41153079)
21. Ohlsson B, Sjoberg K, Alm R, Fredrikson GN (2011) Patients with irritable bowel syndrome and dysmotility express antibodies against gonadotropin- releasing hormone in serum. Neurogastroenterol Motil 23(11):1000-1006. doi: 10.1111/j.1365-2982.2011.01744.x
22. Pendleton H, Ekman R, Olsson R, Ekberg O, Ohlsson B (2009) Motilin concentrations in relation to gastro intestinal dysmotility in diabetes mellitus. Eur J Intern Med 20(6):654-659. doi: 10.1016/j.ejim.2009.05.015
23. Koufman JA, Belafsky PC, Bach KK, Daniel E, Postma GN (2002) Prevalence of esophagitis in patients with pH-documented laryngopharyngeal reflux. Laryngoscope 112(9):1606-1609 (Pubitemid 34977563)
24. Toros SZ, Toros AB, Yuksel OD, Ozel L, Akkaynak C, Naiboglu B (2009) Association of laryngopharyngeal manifestations and gastroesophageal reflux. Eur Arch Otorhinolaryngol 266(3):403-409. doi: 10.1007/s00405-008-0761-2
25. Becher A, Dent J (2011) Systematic review: ageing and gastro-oesophageal reflux disease symptoms, oesophageal function and reflux oesophagitis. Aliment Pharmacol Ther 33(4):442-454. doi: 10.1111/j.1365-2036.2010.04542.x
26. Siupsinskiene N, Adamonis K, Toohill RJ (2007) Quality of life in laryngopharyngeal reflux patients. Laryngoscope 117(3):480-484. doi: 10.1097/MLG.0b013e31802d83cf (Pubitemid 46407758)
27. Carrau RL, Khidr A, Crawley JA, Hillson EM, Davis JK, Pashos CL (2004) The impact of laryngopharyngeal reflux on patient-reported quality of life. Laryngoscope 114(4):670-674 (Pubitemid 38548778)
28. Powitzky ES, Khaitan L, Garrett CG, Richards WO, Courey M (2003) Symptoms, quality of life, videolaryngoscopy, and twenty-four-hour triple-probe pH monitoring in patients with typical and extraesophageal reflux. Ann Otol Rhinol Laryngol 112(10):859-865 (Pubitemid 37255300)